We serve Chemical Name:Methyl propyl disulfide CAS:2179-60-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl propyl disulfide
CAS.NO:2179-60-4
Synonyms:Methyldithiopropane;methyl-propyl-disulfane;Methyl propyl disulphide;2SS1;MFCD00013400;1-(Methyldisulfanyl)propane;Disulfide,methyl propyl;2,3-Dithiahexane;Methyl n-propyl disulfide;EINECS 218-551-2;Disulfide, methyl propyl;1-METHYLDITHIO-PROPANE;Methyl propyl disulfide;Propyl methyl disulfide
Molecular Formula:C4H10S2
Molecular Weight:122.252
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:154.1±0.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.509
PSA:50.60000
Exact Mass:122.022392
LogP:2.83
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993 3/PG 3
Packing Group:III
Contact us for information like Methyldithiopropane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propyl methyl disulfide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl n-propyl disulfide Use and application,MFCD00013400 technical grade,usp/ep/jp grade.
Related News: There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. Methyl propyl disulfide manufacturer This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine. Methyl propyl disulfide supplier There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. Methyl propyl disulfide vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. Methyl propyl disulfide factory The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan.
